Atricure Inc. buy Needham & Company LLC
Start price
29.11.23
/
50%
€29.61
Target price
29.11.24
€44.64
Performance (%)
-
End price
30.11.24
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Atricure Inc. | -3.692% | -3.692% | -52.250% |
| iShares Core DAX® | 0.378% | -1.285% | 21.733% |
| iShares Nasdaq 100 | -0.117% | 3.146% | 17.168% |
| iShares Nikkei 225® | -0.806% | 3.298% | 9.191% |
| iShares S&P 500 | 0.059% | 2.018% | 11.638% |
Comments by Needham___Company_LL for this prediction
In the thread Atricure Inc. diskutieren
AtriCure, Inc. (NASDAQ: ATRC) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $49.00 price target on the stock.
Ratings data for ATRC provided by MarketBeat
In the thread Trading Atricure Inc.
Die von Needham___Company_LL gewählte maximale Laufzeit wurde überschritten